As of June 29, 2022, Mr. Loren Wass, Bionik Laboratories Corp.'s Chief Commercial Officer, employment was terminated other than for cause from all employment and officer positions with the company and its subsidiaries.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% |
|
-.--% | -.--% |
2023 | Bionik Laboratories Corp. Announces Executive Changes | CI |
2023 | Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 12 | |
-5.60% | 182B | |
-4.45% | 102B | |
-4.15% | 66.74B | |
-8.63% | 45.55B | |
+9.70% | 44.89B | |
+6.13% | 40.62B | |
+15.22% | 30.04B | |
+14.80% | 24.34B | |
-6.46% | 23.95B |
- Stock Market
- Equities
- BNKL Stock
- News Bionik Laboratories Corp.
- Bionik Laboratories Corp. Terminates Employment of Loren was as Chief Commercial Officer